Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Lost 20 kg on Mounjaro, cravings vanished — six months maintaining weight

Someone on Reddit says they lost 20 kg (about 44 pounds) while using Mounjaro and have kept the weight off for six months, now weighing 65 kg. They report that after stopping the drug they initially had a strong return of hunger, so they ate only oats with milk three times a day for a short period, and after that the intense cravings went away “for good.” They’re offering to answer questions from people thinking about trying Mounjaro for weight loss. Mounjaro is the brand name for tirzepatide, a medicine that affects how your body handles appetite and blood sugar. It acts on receptors in the body that respond to hormones normally released by the gut when you eat. Those hormones tell your brain you are full and help control blood sugar. In plain terms, Mounjaro can reduce hunger and help people eat less, and it was developed to treat type 2 diabetes and has been used off-label for weight loss. What this post shows is a single person’s experience — an anecdote, not a scientific study. Personal stories like this can be powerful but don’t prove that the same thing will happen for everyone. Clinical trials of tirzepatide do show many people lose significant weight on the drug, but results vary by person and depend on dose, lifestyle, and other factors. The Reddit poster says they had a rebound in hunger right after stopping and managed it with a short, very simple eating plan, after which their cravings subsided. That’s an individual account about how they coped; it doesn’t tell us how common that pattern is or why it happened. Why it matters: people considering Mounjaro for weight loss want to know about the long-term outcome and how hard it is to keep weight off after stopping. This story suggests one possible path: temporary increased appetite after stopping, manageable with a short plan, followed by sustained appetite control. For someone curious or anxious about withdrawal effects, hearing personal tips can be comforting and practical. But it’s only one person’s strategy, not medical advice. Caveats and risks: remember this is not systematic evidence. Stopping weight-loss drugs can produce different responses — some people regain weight, others maintain loss with lifestyle changes, and some struggle with persistent cravings. Tirzepatide has side effects that can include nausea, diarrhea, and, more rarely, pancreatitis or gallbladder issues; it’s prescribed and monitored by doctors for a reason. If you’re thinking about Mounjaro, talk with a healthcare professional about benefits, risks, dosing, and plans for stopping the drug. Also, using someone’s short-term diet (like oats only) without medical oversight might not be safe or sustainable. Bottom line: one person says they kept 20 kg off after stopping Mounjaro by briefly managing rebound hunger, but this single report doesn’t guarantee the same outcome for others — talk to a clinician and look to clinical studies for broader evidence.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE